These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1632 related items for PubMed ID: 8019768

  • 1. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 2. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    Yu SM, Ko FN, Wu TS, Lee JY, Teng CM.
    Eur J Pharmacol; 1994 Apr 11; 256(1):85-91. PubMed ID: 8026563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM.
    J Pharmacol Exp Ther; 1992 Apr 11; 261(1):131-7. PubMed ID: 1532833
    [Abstract] [Full Text] [Related]

  • 5. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar 11; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J, Rolin S, Reynaud D, Qiao N, Kelley LP, Reid HM, Valentin F, Tippins J, Kinsella BT, Masereel B, Pace-Asciak C, Pirotte B, Dogné JM.
    J Pharmacol Exp Ther; 2005 Apr 11; 313(1):293-301. PubMed ID: 15626721
    [Abstract] [Full Text] [Related]

  • 7. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 11; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 8. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec 11; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

  • 9. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
    Brownlie RP, Brownrigg NJ, Butcher HM, Garcia R, Jessup R, Lee VJ, Tunstall S, Wayne MG.
    Br J Pharmacol; 1993 Dec 11; 110(4):1600-6. PubMed ID: 8306107
    [Abstract] [Full Text] [Related]

  • 10. Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles.
    Rolin S, Dogné JM, Michaux C, Delarge J, Masereel B.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Aug 11; 65(2):67-72. PubMed ID: 11545621
    [Abstract] [Full Text] [Related]

  • 11. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB.
    J Pharmacol Exp Ther; 1992 Feb 11; 260(2):832-40. PubMed ID: 1738127
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F, Colombo M, Pierucci L, Volpi D, Dho L, Ukmar G, Rosa B, Salvati P.
    Drugs Exp Clin Res; 1993 Feb 11; 19(6):249-60. PubMed ID: 8013268
    [Abstract] [Full Text] [Related]

  • 13. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

  • 14. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 14; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

  • 15. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS, Kim HM, Lee KS, Khil LY, Mar WC, Ryu CK, Moon CK.
    Biochem Pharmacol; 1997 Jul 15; 54(2):259-68. PubMed ID: 9271330
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    Ogletree ML, Harris DN, Schumacher WA, Webb ML, Misra RN.
    J Pharmacol Exp Ther; 1993 Feb 15; 264(2):570-8. PubMed ID: 8437108
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM, Jones RL, Wilson NH, Marr CG.
    Br J Pharmacol; 1991 Mar 15; 102(3):607-14. PubMed ID: 1364826
    [Abstract] [Full Text] [Related]

  • 18. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb 15; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S, Ogawa N, Suzuki T, Kato K, Ohashi T, Yasuda S, Kato H, Ito Y.
    Chem Pharm Bull (Tokyo); 1996 Apr 15; 44(4):765-77. PubMed ID: 8681409
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
    Ko FN, Yu SM, Kang YF, Teng CM.
    Br J Pharmacol; 1995 Sep 15; 116(2):1801-8. PubMed ID: 8528563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.